Renowned Chemist Janusz Pawliszyn Appointed as Scientific Advisor for AES

Professor Janusz Pawliszyn Joins Advanced Electrophoresis Solutions Ltd.

On March 24, 2025, Advanced Electrophoresis Solutions Ltd. (AES) officially announced the appointment of Professor Janusz Pawliszyn from the University of Waterloo as their new Scientific Advisor. This decision comes as AES looks to further establish its leadership in imaged capillary isoelectric focusing (icIEF) technology and continue driving innovation in the biopharmaceutical industry.

Prof. Pawliszyn is well-respected for his significant contributions to the field of analytical chemistry, particularly for developing icIEF. This innovative technology has notably transformed the way proteins are characterized and quality control is conducted within biopharmaceutical applications. Additionally, he is credited with the invention of solid phase microextraction (SPME), a method that has considerably improved sampling and sample preparation processes across various analytical and laboratory settings.

As one of the leading figures in separation science, Prof. Pawliszyn’s work does not merely end with technology innovation; it has also been pivotal in promoting sustainable methodologies in scientific research. His extensive experience and insights will undoubtedly help AES in reinforcing its commitment to delivering top-notch analytical solutions that cater to all stages of biopharmaceutical development.

AES's Commitment to Innovation

At Advanced Electrophoresis Solutions, the vision is clear: to redefine biopharmaceutical analysis through cutting-edge technology. Their icIEF platform is designed to seamlessly integrate various components of quality control, fractionation, and detection methods. This unique approach helps ensure that the tools they provide are not just innovative but also refined for efficiency and precision. By bringing Prof. Pawliszyn on board, AES aims to further enhance its ability to serve the biopharma industry better, thereby accelerating innovation in therapeutic development.

Contributions and Recognition

Prof. Pawliszyn’s excellence in research and development has earned him numerous awards from esteemed organizations, including the Chemical Institute of Canada (CIC), American Chemical Society (ACS), International Union of Pure and Applied Chemistry (IUPAC), and the UK Chromatographic Society. Such accolades testify to his influential role in both the scientific community and the broader context of separation science.

With decades of research experience, his groundbreaking work serves as a foundation for the advancements in techniques that AES aims to promote. His appointment is poised to unlock new opportunities, paving the way for advancements not only in icIEF technology but also in the overall field of biopharmaceutical analysis and quality control.

A New Chapter for AES

The addition of Prof. Pawliszyn to the AES team represents a remarkable step toward reinforcing the company’s goal of becoming a leader in innovative solutions for the biopharmaceutical sector. As they champion Prof. Pawliszyn's legacy of scientific inquiry and excellence, AES is expected to spearhead next-generation chemistry, manufacturing, and control (CMC) solutions.

In summary, the collaboration between AES and Professor Janusz Pawliszyn signals a new chapter filled with potential for transformative advancements in biopharmaceutical analytics. As the company embraces this change, it continues to uphold its mission of ensuring that the development of therapeutics is efficient, accurate, and reliable.

About AES

Advanced Electrophoresis Solutions Ltd. (AES) is recognized as a pioneering entity in capillary electrophoresis technologies, providing innovative solutions tailored for the biopharmaceutical industry. Specializing in icIEF and other analytical techniques, AES remains dedicated to pushing the boundaries of biotherapeutic development and analysis across the globe.